These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3356206)

  • 21. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
    Smith JW; Longo DL; Urba WJ; Clark JW; Watson T; Beveridge J; Conlon KC; Sznol M; Creekmore SP; Alvord WG
    Blood; 1991 Oct; 78(7):1664-71. PubMed ID: 1912555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of hairy cell leukaemia with recombinant alpha-interferon.
    Bezwoda WR; Hesdorffer CS; Dansey RD; Lewis D
    S Afr Med J; 1987 Nov; 72(10):661-2. PubMed ID: 3686262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced hematologic response to alpha-interferon therapy in patients with hairy cell leukemia showing a peculiar immunologic phenotype.
    Lauria F; Raspadori D; Foa R; Zinzani PL; Buzzi M; Gugliotta L; Macchi S; Tura S
    Cancer; 1990 May; 65(10):2233-6. PubMed ID: 1693308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
    Golomb HM; Dodge R; Mick R; Budman D; Hutchison R; Horning SJ; Schiffer CA
    Leukemia; 1994 Dec; 8(12):2037-40. PubMed ID: 7807991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
    Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
    Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.
    Seymour JF; Estey EH; Keating MJ; Kurzrock R
    Leukemia; 1995 May; 9(5):929-32. PubMed ID: 7769859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
    Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
    Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to intermediate and standard doses of IFN-beta in hairy-cell leukaemia.
    Liberati AM; Fizzotti M; Di Clemente F; Senatore M; Berruto P; Falini B; Martelli MF; Grignani F
    Leuk Res; 1990; 14(9):779-84. PubMed ID: 2232850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon in the treatment of hairy cell leukemia.
    Thompson JA; Fefer A
    Cancer; 1987 Feb; 59(3 Suppl):605-9. PubMed ID: 3542183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia. Therapeutic and immunologic results.
    Foon KA; Maluish AE; Abrams PG; Wrightington S; Stevenson HC; Alarif A; Fer MF; Overton WR; Poole M; Schnipper EF
    Am J Med; 1986 Mar; 80(3):351-6. PubMed ID: 3953613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of hairy-cell leukemia using interferon alfa].
    Neuwirtová R; Cermák J; Kvasnicka J; Sedlácková M
    Cas Lek Cesk; 1989 Aug; 128(34):1065-70. PubMed ID: 2790914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
    Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
    Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia.
    Gastl G; Denz H; Abbrederis C; Huber H; Troppmair J; Wiegele J; Niederwieser D; Flener R; Huber C
    Onkologie; 1985 Jun; 8(3):143-4. PubMed ID: 3895095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hairy cell leukemia: preliminary results with alpha 2 (r) interferon.
    Mandelli F; Annino L; Cafolla A; De Rossi G; Bianco P; Fontana L; Dianzani F
    Tumori; 1986 Apr; 72(2):153-6. PubMed ID: 3705188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
    Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
    Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
    Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
    Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients.
    Schwarzinger I; Bettelheim P; Chott A; Herold C; Hinterberger W; Köller U; Kos M; Neumann E; Radaszkiewicz T; Lechner K
    Wien Klin Wochenschr; 1988 Jan; 100(2):47-51. PubMed ID: 3348041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
    Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
    Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hairy cell leukemia: an interferon deficient disease?
    Hofmann V; Fehr J; Sauter C; Ottino J
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():33-7. PubMed ID: 3833328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
    Ho AD; Thaler J; Mandelli F; Lauria F; Zittoun R; Willemze R; McVie G; Marmont AM; Prümmer O; Stryckmans P
    J Clin Oncol; 1989 Oct; 7(10):1533-8. PubMed ID: 2789273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.